arrow
L

Laure Gossec

Sorbonne Universite
H指数:94
被引数:4.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Interventions aimed at advancing gender equity in rheumatology: Insights from the Coalition for Health and Gender Equity (CHANGE) survey

旨在促进风湿病学领域性别平等的干预措施:来自健康与性别平等联盟(CHANGE)调查的见解

2026-09-010
PRE
Guselkumab Improves Patient-Reported Outcomes Among Participants with Psoriatic Arthritis and Inadequate Response to Tumor Necrosis Factor Inhibitors in the COSMOS Study

在COSMOS研究中,Guselkumab可改善银屑病关节炎和对肿瘤坏死因子抑制剂反应不足的参与者的患者报告结局

2026-01-230
OAAI
Do the Psoriatic Arthritis Impact of Disease’s cutoffs vary across ethnicities? Insights from the TACTIC initiative
2026-01-100
PRE
Impact of concomitant fibromyalgia on patient-reported outcomes and inflammatory markers in psoriatic arthritis: a multinational cross-sectional study

银屑病关节炎中伴发纤维肌痛对患者报告结局和炎症标志物的影响:一项跨国横断面研究

2025-12-080
PRE
Efficacy of Risankizumab across distinct PsA phenotypes identified with machine learning analytics using data from biologic DMARD-Naïve patients in two phase 3 clinical trials

利司那木单抗在生物制剂初治患者两项III期临床试验中,针对通过机器学习分析识别的不同银屑病关节炎表型的疗效

2025-11-290
OAAI
Early peripheral psoriatic arthritis: Baseline features of the first 186 patients in the French Nationwide APACHE Cohort

早期外周型银屑病关节炎:法国全国性APACHE队列中前186例患者的基线特征

2025-05-270
OA
Summary of Research: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies

研究总结:Bimekizumab在银屑病关节炎患者中的安全性与有效性:两项III期研究2年结果

2025-05-100
OA
Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies (vol 11, pg 1363, 2024)

贝美克单抗在银屑病关节炎患者中的安全性与有效性:两项III期研究2年结果(卷11,页1363,2024)

2025-05-050
OAAI
Bimekizumab-treated patients with active psoriatic arthritis showed sustained improvements in pain and fatigue: up to 2-year results from two Phase 3 studies

接受Bimekizumab治疗的具有活动性银屑病关节炎的患者在疼痛和疲劳方面显示出持续的改善:两项III期研究的2年结果。

2025-04-280
PRE
Guselkumab and IL-17 inhibitors improve patient-perceived impact of psoriatic arthritis similarly: 6-month interim results of the PsABIOnd observational cohort study

Guselkumab和IL-17抑制剂对银屑病关节炎患者感知影响的改善效果相似:PsABIOnd观察性队列研究的6个月中期结果

2025-04-280
PRE
Discordance between patient and physician global assessments of psoriatic arthritis activity: an observational study in 13 Arab countries
2025-03-120
PRE
Factors associated with dietary practices and beliefs on food of patients with rheumatic and musculoskeletal diseases: A multicentre cross-sectional study
2025-01-010
OAAI
Unmet needs in axial spondyloarthritis. Proceedings of the French spondyloarthritis taskforce workshop
2024-12-014
OAAI